JPS5649314A - Lasting pharmaceutical composition having prolonged action and its preparation - Google Patents
Lasting pharmaceutical composition having prolonged action and its preparationInfo
- Publication number
- JPS5649314A JPS5649314A JP8520979A JP8520979A JPS5649314A JP S5649314 A JPS5649314 A JP S5649314A JP 8520979 A JP8520979 A JP 8520979A JP 8520979 A JP8520979 A JP 8520979A JP S5649314 A JPS5649314 A JP S5649314A
- Authority
- JP
- Japan
- Prior art keywords
- constituent
- base component
- polyethylene oxide
- prolonged action
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002035 prolonged effect Effects 0.000 title abstract 2
- 230000002045 lasting effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000470 constituent Substances 0.000 abstract 5
- 239000007787 solid Substances 0.000 abstract 5
- 229940079593 drug Drugs 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 abstract 1
- ZBBHBTPTTSWHBA-UHFFFAOYSA-N Nicardipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)CC=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ZBBHBTPTTSWHBA-UHFFFAOYSA-N 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 abstract 1
- 229960001597 nifedipine Drugs 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8520979A JPS5649314A (en) | 1979-07-05 | 1979-07-05 | Lasting pharmaceutical composition having prolonged action and its preparation |
CA000354396A CA1146866A (en) | 1979-07-05 | 1980-06-19 | Process for the production of sustained release pharmaceutical composition of solid medical material |
CH5045/80A CH648484A5 (de) | 1979-07-05 | 1980-07-01 | Pharmazeutische zubereitung eines festen medikamentmaterials. |
DE3024858A DE3024858C2 (de) | 1979-07-05 | 1980-07-01 | Verfahren zur Herstellung einer anhaltend freigebenden pharmazeutischen Zubereitung eines festen Medikamentenmaterials |
US06/165,244 US4343789A (en) | 1979-07-05 | 1980-07-02 | Sustained release pharmaceutical composition of solid medical material |
IT23228/80A IT1132169B (it) | 1979-07-05 | 1980-07-03 | Composizione farmaceutica a cessione prolungata contenente un medicamento solido e procedimento per la sua preparazione |
FR8014827A FR2460667A1 (fr) | 1979-07-05 | 1980-07-03 | Composition pharmaceutique a liberation prolongee a base d'une substance medicamenteuse solide |
SE8004938A SE448342B (sv) | 1979-07-05 | 1980-07-04 | Farmaceutisk komposition med depaverkan innehallande nicardipin, nicardipinsalt, nifedipin eller indometacin i amorf form |
ES493152A ES8200557A1 (es) | 1979-07-05 | 1980-07-04 | Un procedimiento para la preparacion de una composicion farmaceutica de cesion sostenida de un producto medio solido. |
GB8022184A GB2053681B (en) | 1979-07-05 | 1980-07-07 | Sustained release pharmaceutical composition |
US06/403,007 US4404183A (en) | 1979-07-05 | 1982-07-29 | Sustained release pharmaceutical composition of solid medical material |
US06/790,639 US4673564A (en) | 1979-07-05 | 1985-10-23 | Sustained release pharmaceutical composition of solid medical material |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8520979A JPS5649314A (en) | 1979-07-05 | 1979-07-05 | Lasting pharmaceutical composition having prolonged action and its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5649314A true JPS5649314A (en) | 1981-05-02 |
JPH029007B2 JPH029007B2 (enrdf_load_stackoverflow) | 1990-02-28 |
Family
ID=13852191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8520979A Granted JPS5649314A (en) | 1979-07-05 | 1979-07-05 | Lasting pharmaceutical composition having prolonged action and its preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5649314A (enrdf_load_stackoverflow) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5948415A (ja) * | 1982-08-12 | 1984-03-19 | フアイザ−・インコ−ポレ−テツド | 長時間活性持続マトリツクス錠剤 |
WO1992018109A1 (fr) * | 1991-04-15 | 1992-10-29 | Yamanouchi Pharmaceutical Co., Ltd. | Preparation solide rapidement soluble |
JPWO9706781A1 (enrdf_load_stackoverflow) * | 1995-08-11 | 1997-02-27 | ||
JP2000229888A (ja) * | 1999-02-10 | 2000-08-22 | Pfizer Prod Inc | マトリックス制御放出デバイス |
JP2001010951A (ja) * | 1992-09-18 | 2001-01-16 | Yamanouchi Pharmaceut Co Ltd | ハイドロゲル徐放性製剤 |
JP3140465B2 (ja) * | 1992-09-18 | 2001-03-05 | 山之内製薬株式会社 | ハイドロゲル徐放性製剤 |
JP2003513904A (ja) * | 1999-11-12 | 2003-04-15 | アボット・ラボラトリーズ | 固体分散剤中の結晶化阻害剤 |
JP2006511541A (ja) * | 2002-12-17 | 2006-04-06 | アボット ゲーエムベーハー ウント カンパニー カーゲー | フェノフィブル酸、その生理学的に許容し得る塩または誘導体を含有してなる製剤 |
WO2007136085A1 (ja) | 2006-05-23 | 2007-11-29 | Mochida Pharmaceutical Co., Ltd. | スピロ四環系化合物 |
WO2011162300A1 (ja) | 2010-06-23 | 2011-12-29 | アステラス製薬株式会社 | 縮合ピリジン化合物塩の結晶 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04287601A (ja) * | 1991-03-15 | 1992-10-13 | Kubota Corp | ロータリ耕耘機用弾性カバーの製造方法 |
-
1979
- 1979-07-05 JP JP8520979A patent/JPS5649314A/ja active Granted
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5948415A (ja) * | 1982-08-12 | 1984-03-19 | フアイザ−・インコ−ポレ−テツド | 長時間活性持続マトリツクス錠剤 |
WO1992018109A1 (fr) * | 1991-04-15 | 1992-10-29 | Yamanouchi Pharmaceutical Co., Ltd. | Preparation solide rapidement soluble |
US6699503B1 (en) | 1992-09-18 | 2004-03-02 | Yamanuchi Pharmaceutical Co., Ltd. | Hydrogel-forming sustained-release preparation |
JP2001010951A (ja) * | 1992-09-18 | 2001-01-16 | Yamanouchi Pharmaceut Co Ltd | ハイドロゲル徐放性製剤 |
JP3140465B2 (ja) * | 1992-09-18 | 2001-03-05 | 山之内製薬株式会社 | ハイドロゲル徐放性製剤 |
US6436441B1 (en) | 1992-09-18 | 2002-08-20 | Yamanouchi Pharmaceutical Co., Ltd. | Hydrogel-forming sustained-release preparation |
JPWO9706781A1 (enrdf_load_stackoverflow) * | 1995-08-11 | 1997-02-27 | ||
JP2000229888A (ja) * | 1999-02-10 | 2000-08-22 | Pfizer Prod Inc | マトリックス制御放出デバイス |
JP2005320354A (ja) * | 1999-02-10 | 2005-11-17 | Pfizer Prod Inc | マトリックス制御放出デバイス |
JP2003513904A (ja) * | 1999-11-12 | 2003-04-15 | アボット・ラボラトリーズ | 固体分散剤中の結晶化阻害剤 |
JP2013224297A (ja) * | 1999-11-12 | 2013-10-31 | Abbott Lab | 固体分散剤中の結晶化阻害剤 |
JP2006511541A (ja) * | 2002-12-17 | 2006-04-06 | アボット ゲーエムベーハー ウント カンパニー カーゲー | フェノフィブル酸、その生理学的に許容し得る塩または誘導体を含有してなる製剤 |
WO2007136085A1 (ja) | 2006-05-23 | 2007-11-29 | Mochida Pharmaceutical Co., Ltd. | スピロ四環系化合物 |
WO2011162300A1 (ja) | 2010-06-23 | 2011-12-29 | アステラス製薬株式会社 | 縮合ピリジン化合物塩の結晶 |
Also Published As
Publication number | Publication date |
---|---|
JPH029007B2 (enrdf_load_stackoverflow) | 1990-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5663923A (en) | Suppository base composition | |
HK48585A (en) | New galenical compositions containing cyclosporins | |
JPS5649314A (en) | Lasting pharmaceutical composition having prolonged action and its preparation | |
JPS5525430A (en) | Thickening and gelling agent | |
KR910014120A (ko) | 피모벤단의 경구용 약제학적 제제 | |
JPS56110612A (en) | Readily disintegrable and absorbable compression molded article of slightly soluble drug | |
JPS5668619A (en) | Nifedipine-containing solid composition | |
JPS57187306A (en) | Production of highly water-absorbing polymer material having high water absorption rate | |
JPS5522631A (en) | Readily absorbable nifedipine preparation | |
JPS5218832A (en) | Method of making cosmetic preparation | |
JPS5750914A (en) | Betamethasone external pharmaceutical | |
GR3002420T3 (en) | Medicinal formulation | |
IE802102L (en) | Pyrrolecarboxylic acid esters | |
JPS53139716A (en) | Pharmaceutical preparation of stable prostaglandine | |
IT1204778B (it) | Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale | |
JPS55160713A (en) | Stable aqueous powder dispersion composition | |
JPS5612306A (en) | Novel base for external preparation | |
JPS55129220A (en) | Composition for solid preparation containing hardly soluble medicinal component having rapid action and high bioavailability | |
WO2000044334A3 (en) | Novel injectable muscle relaxant formulations | |
EP0056681A3 (en) | Levonantradol and n-methyllevonantradol formulations | |
JPS5366938A (en) | Production of phthtalocyaninesulfonic acids | |
JPS55102510A (en) | Hair rinse composition | |
JPS53101535A (en) | Deodorant comosition | |
JPS5742618A (en) | Plaster and its preparation | |
SE8204792L (sv) | N-metyl-d-glukaminsalt av 3,4-dihydro-5-metyl-6-(2-metyl-propyl)-4-oxotieno(2,3-d)pyrimidin-2-karboxylsyra och farmaceutisk komposition innehallande detta salt |